Skip to content
value.today

Direct Flow Medical, Inc

Total raised
$98 M
3 rounds on record
Latest round
$27 M
Mar 2016
First round on record
Sep 2009
Today
Private
No later event on record

Funding rounds

3 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Direct Flow Medical, Inc
MonthRaisedRaiseSizeInvestorsSoldFiling
Mar 2016$27 MNo. 3$10 to $50 million

Direct Flow Medical, Inc: Raise no. 3, Mar 2016

Investors in this round

11 investors had bought by the notice of Jul 22, 2016: 11 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$27 M of $32 M offered; $5 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, debt, options or other rights to buy securities, securities to be acquired by exercising them, other: Sale and issuance of Series A-1 Preferred Stock, Series AA Preferred Stock, Convertible Note, Warrant to purchase Series A-1 or Preferred Stock, Series A-1 or Preferred Stock upon exercise; and the un
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Dan T. Lemaitre · Executive Officer, Director
  • David T. Boyle · Executive Officer
  • Gordon T. Bishop · Executive Officer, Director
  • George T. Fazio · Director
  • Greg T. Madden · Director
  • Paul T. LaViolette · Director
  • Yuval T. Binur · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by David Boyle, Chief Financial Officer. Source: SEC Form D and 1 amendment, newest notice filed Jul 22, 2016. Read the notice at the SEC.

equity, debt, optionsSEC
Sep 2014$31 MNo. 2$10 to $50 million

Direct Flow Medical, Inc: Raise no. 2, Sep 2014

Investors in this round

36 investors had bought by the notice of Apr 14, 2016: 36 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$31 M of $59 M offered; $28 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them, other: Sale and issuance of (i) Series C-1 Preferred Stock, (ii) Warrants to purchase Series C-1 Preferred Stock, (iii) Series C-1 Preferred Stock upon exercise of Warrants, and (iv) Common Stock issuable up
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Chris T. Richardson · Executive Officer
  • Dan T. Lemaitre · Executive Officer, Director
  • Dan T. Rose · Executive Officer
  • David T. Boyle · Executive Officer
  • Gordon T. Bishop · Executive Officer, Director
  • George T. Fazio · Director
  • Greg T. Madden · Director
  • Paul T. LaViolette · Director
  • Yuval T. Binur · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Total offering amount includes the warrant purchase price and assumes the exercise of warrants (total of $22,115,774).”

Signed by David Boyle, Chief Financial Officer. Source: SEC Form D and 1 amendment, newest notice filed Apr 14, 2016. Read the notice at the SEC.

equity, optionsSEC
Sep 2009$40 MNo. 1$10 to $50 million

Direct Flow Medical, Inc: Raise no. 1, Sep 2009

Investors in this round

18 investors had bought by the notice of Apr 17, 2012: 18 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$40 M of $43 M offered; $2 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, other: Sale and issuance of Series C Preferred Stock and the underlying Common Stock issuable upon conversion thereof
Exemption claimed
  • 06
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Bernard E. Lyons · Executive Officer, Director
  • Brian E. Sheahan · Executive Officer
  • David R. Elizondo · Executive Officer
  • Gordon E. Bishop · Executive Officer, Director
  • Mark E. Weeks · Executive Officer
  • Mike E. Burgess · Executive Officer
  • J. Daniel E. Cole · Director
  • Jeani E. Delagardelle · Director
  • John E. Sullivan · Director
  • Michael E. DeVries · Director
  • Paul E. LaViolette · Director
  • Renee E. Ryan · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Bernard E. Lyons, Chief Executive Officer. Source: SEC Form D and 1 amendment, newest notice filed Apr 17, 2012. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Direct Flow Medical, Inc chose not to state its revenue in its newest notice of a funding round (Jul 2016).

    SEC Form D · Jul 2016

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Jul 2016

That is all the official record says: Direct Flow Medical, Inc has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Direct Flow Medical, Inc is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 3 rounds above had up to 36 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Direct Flow Medical, Inc
NameRoleNamed in
Dan T. LemaitreExecutive officerJul 2016
David T. BoyleExecutive officerJul 2016
Gordon T. BishopExecutive officerJul 2016
Chris T. RichardsonExecutive officerApr 2016
Dan T. RoseExecutive officerApr 2016
Laura T. NagelExecutive officerMar 2016
Bernard E. LyonsExecutive officerDec 2014
Charles J. DavidsonExecutive officerDec 2014
Dan R. RoseExecutive officerDec 2014
David R. ElizondoExecutive officerDec 2014
Gordon E. BishopExecutive officerDec 2014
Julie R. SelstromExecutive officerDec 2014
Mike E. BurgessExecutive officerDec 2014
Brian E. SheahanExecutive officerApr 2012
Mark E. WeeksExecutive officerApr 2012
Bernard LyonsExecutive officerOct 2009
Brian SheahanExecutive officerOct 2009
Gordon BishopExecutive officerOct 2009
Jay ShukertExecutive officerOct 2009
Mark WeeksExecutive officerOct 2009
Dan T. LemaitreDirectorJul 2016
George T. FazioDirectorJul 2016
Gordon T. BishopDirectorJul 2016
Greg T. MaddenDirectorJul 2016
Paul T. LaVioletteDirectorJul 2016
Yuval T. BinurDirectorJul 2016
Bernard E. LyonsDirectorDec 2014
Gordon E. BishopDirectorDec 2014
J. Daniel E. ColeDirectorDec 2014
Jeani E. DelagardelleDirectorDec 2014
Lee E. WrubelDirectorDec 2014
Michael E. DeVriesDirectorDec 2014
Paul E. LaVioletteDirectorDec 2014
Renee E. RyanDirectorDec 2014
John E. SullivanDirectorApr 2012
Bernard LyonsDirectorOct 2009
Gordon BishopDirectorOct 2009
J. Daniel ColeDirectorOct 2009
Jeani DelagardelleDirectorOct 2009
Lee WrubelDirectorOct 2009